Introduction/aims: In 1986 Wain et al. coined the term Basaloid Squamous Cell Carcinoma (BSCC) and it is only since then that this condition has been recognised as a separate entity….
Stress related hormones and their receptors have been involved with cancer. The aim of this study was to evaluate the expression of β2 adrenergic receptor (β2-AR) by malignant cells in…
Objective: This study aimed to investigate the roles of the epidermal growth factor receptor (EGFR) family in oral leukoplakia (LP). Patients and methods: The expression of four EGFR-like receptors were…
More than 90% of the oral cancer is histopathologically squamous cell carcinoma (SCC). According to the clinical behavior and histopathological features, we hypothesize that oral SCC (OSCC) is originating from…
Objective: Although much data has been published regarding the incidence and characteristics of bisphosphonate-related osteonecrosis of the jaws (BRONJ) secondary to intravenous and oral bisphosphonate use, little information is available…
Osteonecrosis of the jaw (ONJ) has emerged as a new adverse drug reaction (ADR) related to treatment with bisphosphonates and possibly other drugs. Objectives: To assess the officially reported numbers…
Background: Mucormycosis is a serious and rare acute disease, potentially fatal. Affects immunocompromised patients. The most common form is rhinocerebral. Rhinosinusitis, facial pain, proptosis and ophthalmoplegia are the common manifestations….
Currently a combination of polyglycolic acid sheet (PGA) and spraying of fibrin glue is tried to use for repair after resection of oral tumors. We report two cases in which…
Epidermal growth factor is a single-chain polypeptide consisting of 53 amino acids and has a potent mitogenic activity that stimulates proliferation of various normal and neoplastic cells through the interaction…
Introduction: Temporal artery biopsy is the gold standard for the diagnosis of giant cell arteritis (GCA). There is disagreement over how long the temporal artery specimen should be, i.e. 0.5…
